会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明专利
    • 室内用建材
    • 室内材料
    • JP2014198338A
    • 2014-10-23
    • JP2014100560
    • 2014-05-14
    • 株式会社東芝Toshiba Corp東芝マテリアル株式会社Toshiba Materials Co Ltd
    • NAKANO KAYOSATO HIKARISHIRAKAWA YASUHIROFUSE KEIICHIOKAMURA MASAMIKASAMATSU SHINYA
    • B01J35/02B01J23/30B01J23/34B01J23/652B01J23/68B01J23/85B01J27/122C09D5/16C09D7/12E04B1/92E04F13/02
    • 【課題】照度が低い日常的な室内環境等においても、良好な光触媒性能を得ることが可能な室内用建材を提供する。【解決手段】室内用建材は、酸化タングステン粉末または酸化タングステン複合材粉末を具備する可視光応答型光触媒粉末を表面に存在させた基材を具備する。可視光応答型光触媒粉末は、流通式装置に0.2gの試料を入れた状態で、初期濃度10ppmのアセトアルデヒドガスを140mL/minで流して測定したガス濃度において、光照射前のガス濃度をA、光照射から15分以上経過し、かつ安定したときのガス濃度をBとし、ガス濃度Aとガス濃度Bから[式:(A−B)/A?100]に基づいて算出した値をガス分解率(%)としたとき、波長が380nm以上のみの光で照度が200lxの可視光を照射した際に5%以上のガス分解率を有する。【選択図】なし
    • 要解决的问题:提供即使在照明低的日常室内环境等中也能够提供良好的光催化性能的室内外壳材料。解决方案:室内壳体材料包括在表面上设置有可见光响应性 包含氧化钨粉末或氧化钨复合材料粉末的光催化剂粉末。 当可见光响应性光催化剂粉末当以380nm以上的波长的可见光和200lx的照度照射时,其气体分解率为5%以上,其中气体分解率如下定义。 在流式装置中,放置光催化剂试样0.2g,初始浓度为10ppm的乙醛气体以140mL / min的速度流通,测定气体浓度; 当光照射前的气体浓度为A时,由光照射经过15分钟以上的气体浓度,其值稳定后,用B表示气体分解率(%),根据 [等式(AB)/ A×100]。
    • 8. 发明专利
    • Antiviral filter for air conditioner
    • 空气调节器的防毒过滤器
    • JP2011212613A
    • 2011-10-27
    • JP2010084262
    • 2010-03-31
    • Toshiba CorpToshiba Materials Co Ltd東芝マテリアル株式会社株式会社東芝
    • SASAKI RYOTONAKANO KAYOSATO HIKARIKUSAKA TAKAOKASAMATSU SHINYAFUKUSHI DAISUKE
    • B01J35/02A61L9/00A61L9/01A61L9/16B01D39/14B01D39/16B01D39/18B01D53/86B01J35/10
    • PROBLEM TO BE SOLVED: To provide a filter for an air conditioner which has high antiviral property even under irradiation with visible light of low light intensity.SOLUTION: The filter for an air conditioner includes at least one selected from tungsten oxide particles and composite tungsten oxide particles. When a test piece coated with the particles within the range of 0.01 mg/cmor more and 40 mg/cmor less, is inoculated with at least one selected from a low pathogenic avian influenza virus (H9N2), a highly pathogenic avian influenza virus (H5N1), and a swine influenza virus, the test piece is irradiated with visible light for 24 hours, and then the virus titer is evaluated, the inactivation effect R of the particles, represented by [R=logC-logA] (wherein C is a virus titer TCIDafter preserving an unprocessed test piece for 24 hours under visible light irradiation, and A is a virus titer TCIDafter preserving the test piece coated with the particles for 24 hours under visible light irradiation), is 1 or more.
    • 要解决的问题:提供即使在低光强度的可见光照射下也具有高抗病毒性的空调机的过滤器。解决方案:空调机的过滤器包括选自氧化钨颗粒和复合钨氧化物中的至少一种 粒子。 当用0.01mg / cm 3以上且40mg / cm 3以下的颗粒涂布的试片接种至少一种选自低致病性禽流感病毒(H9N2),高致病性禽流感病毒(H5N1) )和猪流感病毒,用可见光照射试验片24小时,然后评价病毒滴度,由[R = logC-logA]表示的颗粒的失活作用R(其中C为 ),在可见光照射下保存未经处理的试验片24小时后,病毒滴度TCID为1以上,A为在可见光照射下保存了粒子24小时后的病毒滴度TCID)。
    • 9. 发明专利
    • Antivirus medical drape
    • 抗病毒药物
    • JP2011212298A
    • 2011-10-27
    • JP2010084261
    • 2010-03-31
    • Toshiba CorpToshiba Materials Co Ltd東芝マテリアル株式会社株式会社東芝
    • KASAMATSU SHINYANAKANO KAYOSATO HIKARIKUSAKA TAKAOSASAKI RYOTOFUKUSHI DAISUKE
    • A61B19/08
    • PROBLEM TO BE SOLVED: To provide a medical drape showing high antivirus performance under visible light irradiation with low illuminance.SOLUTION: The medical drape includes at least one kind of fine particle selected out of tungsten oxide particles and tungsten oxide composite material particles. When at least one kind of virus selected out of weakly pathogenic avian influenza virus (H9N2), highly pathogenic avian influenza virus (H5N1), and swine influenza virus is inoculated on a test piece on which the fine particles are attached within a range of 0.01 mg/cmor more and of 40 mg/cmor less, and the virus titer after the irradiation with visible light for 24 hours is evaluated, the fine particle has an inactivation effect R of 1 or higher which is expressed by [R=logC-logA] (C is a virus titer TCIDafter preserving an unprocessed test piece under visible light for 24 hours, and A is a virus titer TCIDafter preserving the test piece on which the fine particles are applied under visible light for 24 hours).
    • 要解决的问题:提供一种在低照度的可见光照射下显示出高抗病毒性能的医用罩。解决方案:医用覆盖物包括从氧化钨颗粒和氧化钨复合材料颗粒中选出的至少一种细颗粒。 当将至少一种从弱致病性禽流感病毒(H9N2)中选出的病毒,将高致病性禽流感病毒(H5N1)和猪流感病毒接种在细颗粒附着的试片上,范围为0.01 mg / cm 3以上,40mg / cm 3以下,评价用可见光照射24小时后的病毒滴度,细粉末为[R = logC-logA]表示的失活效果R为1以上 ](C是在可见光下保存未加工的试验片24小时之后的病毒滴度TCID,A是在可见光下保护24小时后将细颗粒保存在其上的试验片,A为病毒滴度TCID)。
    • 10. 发明专利
    • Antivirus mask
    • ANTIVIRUS面膜
    • JP2011072677A
    • 2011-04-14
    • JP2009228854
    • 2009-09-30
    • Toshiba CorpToshiba Materials Co Ltd東芝マテリアル株式会社株式会社東芝
    • SATO HIKARINAKANO KAYOKUSAKA TAKAOKASAMATSU SHINYASASAKI RYOTOFUKUSHI DAISUKE
    • A62B18/02
    • PROBLEM TO BE SOLVED: To solve the following problem: there is no antivirus mask made of a photocatalytic material showing antivirus performance under general indoor illumination or visible light irradiation with low illuminance. SOLUTION: The antivirus mask includes: at least one kind of fine particles selected from among tungsten oxide particles and tungsten oxide composite material particles. When at least one kind of virus selected from among weakly pathogenic avian influenza virus (H9N2), highly pathogenic avian influenza virus (H5N1) and swine influenza virus is inoculated on a test piece where the fine particles are attached within the range of ≥0.01 mg/cm 2 and ≤40 mg/cm 2 and the virus titer after the irradiation of visible light for 24 hours is evaluated, the fine particle has an inactivation effect R of 1 or greater, which is expressed by [R=logC-logA] (C is a virus titer TCID 50 after preserving the unprocessed test piece under the visible light for 24 hours and A is a virus titer TCID 50 after preserving the test piece with the particles applied thereon under the visible light for 24 hours). COPYRIGHT: (C)2011,JPO&INPIT
    • 要解决的问题:解决以下问题:在一般的室内照明或低照度的可见光照射下,没有显示抗病毒性能的光催化材料制成的防毒面具。 防毒面具包括:选自氧化钨粒子和氧化钨复合材料粒子中的至少一种微粒子。 当将至少一种选自弱致病性禽流感病毒(H9N2),高致病性禽流感病毒(H5N1)和猪流感病毒)的病毒接种在细颗粒附着在≥0.01mg范围内的试片上时 评估了可见光照射24小时后的病毒滴度,细粉末的灭活效果R为1, 或更高,其在可见光下保存未加工的试验片24小时后由[R = logC-logA]表示(C为病毒滴度TCID 50 ,A为病毒滴度TCID < 在可见光下将颗粒保存在其上24小时后,保持SB> 50 )。 版权所有(C)2011,JPO&INPIT